A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intravenous ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With st Elevated Acute Myocardial Infarction (Stemi)

NCT00883727 Phase 1/Phase 2 COMPLETED

This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction.

Details

Lead sponsor	Stempeutics Research Pvt Ltd
Phase	Phase 1/Phase 2
Status	COMPLETED
Enrolment	20
Start date	2009-04
Completion	2012-08

Conditions

• Myocardial Infarction

Interventions

• Stem cell
• Plasmalyte A

Primary outcomes

• AE and ECG parameters — 6 months

Countries

India